MolNFT v1 · #92655 · protein
Crystal structure of plasmodium falciparum erythrocyte binding antigen 140 (pfeba-140/BAEBL)
4GF2: “Crystal structure of plasmodium falciparum erythrocyte binding antigen 140 (pfeba-140/BAEBL)”. X-ray diffraction, 11 pockets (best druggability 0.69). MolNFT v1 #92655 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4GF2
- Type
- protein
- Length
- 595 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Erythrocyte binding antigen 140
- UniProt
- Q8WS31
- Pockets
- 11 · best druggability 0.69
Structure
x-ray diffraction · 1 distinct chain · 67% helix, 2% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Erythrocyte binding antigen 140 | protein | 595 | 67% helix, 2% strand | Q8WS31 |
Ligands and binding sites
- GOL · Glycerol · additive · 15 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
11 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 552 | 0.69 | 0.78 | 58 | empty |
| 2 | 50 | 0.67 | 0.96 | 17 | GOL |
| 3 | 334 | 0.65 | 0.80 | 41 | GOL |
| 4 | 135 | 0.55 | 0.82 | 19 | empty |
| 5 | 108 | 0.40 | 0.76 | 18 | GOL |
Modifications
Observed in the structure: 13 disulfide (disulfide).
Compared structures
- 4GF2 · Crystal structure of Plasmodium falciparum Erythrocyte Binding Antigen 140… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q8WS31
- Elsewhere: RCSB PDB 4GF2 · PDBe 4GF2 · UniProt Q8WS31
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.